The Role of Cosmetology in an Effective Treatment of Rosacea: A Narrative Review

References

• Marson JW, Baldwin HE. Rosacea: a wholistic review and update from pathogenesis to diagnosis and therapy. Int J Dermatol. 2020;59(6):e175–e182. doi:10.1111/ijd.14757
   PubMed Web of Science ®Google Scholar
• Clanner-Engelshofen BM, Bernhard D, Dargatz S, et al. S2k guideline: rosacea. J Dtsch Dermatol Ges. 2022;20:1147–1165. doi:10.1111/ddg.14849
   Web of Science ®Google Scholar
• van Zuuren EJ, Arents BWM, van der Linden MMD, et al. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021;22(4):457–465. doi:10.1007/s40257-021-00595-7
   PubMed Web of Science ®Google Scholar
• Vemuri RC, Gundamaraju R, Sekaran SD, Manikam R. Major pathophysiological correlations of rosacea: a complete clinical appraisal. Int J Med Sci. 2015;12(5):387–396. doi:10.7150/ijms.10608
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang Q, Song D, Liu X, Wang L, Jiang X. A cross-sectional study on the relationship between rosacea severity and quality of life or psychological state. Clin Cosmet Investig Dermatol. 2022;15:2807–2816. doi:10.2147/CCID.S390921
   PubMed Web of Science ®Google Scholar
• Nowicka D, Chilicka K, Dzieńdziora-Urbińska I, Szyguła R. Skincare in rosacea from the cosmetologist’s perspective: a narrative review. J Clin Med. 2022;12(1):115. doi:10.3390/jcm12010115
   PubMed Web of Science ®Google Scholar
• Lynn A, Chang S, Raber I, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548–1555. doi:10.1038/jid.2015.53
   PubMed Web of Science ®Google Scholar
• Daou H, Paradiso M, Hennessy K, Seminario-Vidal L. Rosacea and the microbiome: a systematic review. Dermatol Ther. 2021;11(1):1–12. doi:10.1007/s13555-020-00460-1
   PubMed Web of Science ®Google Scholar
• Hu XM, Li ZX, Zhang DY, et al. Current research and clinical trends in rosacea pathogenesis. Heliyon. 2022;8(10):e10874. doi:10.1016/j.heliyon.2022.e10874
   PubMed Web of Science ®Google Scholar
• Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case control study using standardized skin surface biopsy. Br J Dermatol. 1993;128(6):650–659. doi:10.1111/j.1365-2133.1993.tb00261.x
   PubMed Web of Science ®Google Scholar
• Aktaş Karabay E, Aksu Çerman A. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020;95(2):187–193. doi:10.1016/j.abd.2019.08.023
   PubMed Web of Science ®Google Scholar
• Jarmuda S, McMahon F, Żaba R, et al. Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients. J Med Microbiol. 2014;63(Pt 2):258–262. doi:10.1099/jmm.0.065136-0
   PubMedGoogle Scholar
• Szkaradkiewicz A, Chudzicka-Strugała I, Karpiński TM, et al. Bacillus oleronius and Demodex mite infestation in patients with chronic blepharitis. Clin Microbiol Infect. 2012;18(10):1020–1025. doi:10.1111/j.1469-0691.2011.03704.x
   PubMed Web of Science ®Google Scholar
• Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176:100–106. doi:10.1111/bjd.14930
   PubMed Web of Science ®Google Scholar
• Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16(4):328–333. doi:10.1046/j.1468-3083.2002.00497.x
   PubMed Web of Science ®Google Scholar
• Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 1998;93(2):220–222. doi:10.1111/j.1572-0241.1998.00220.x
   PubMed Web of Science ®Google Scholar
• Jørgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31:2010–2015. doi:10.1111/jdv.14352
   PubMed Web of Science ®Google Scholar
• Bonamigo RR, Leite CS, Wagner M, Bakos L. Rosacea and Helicobacter pylori: interference of systemic antibiotics in the study of possible association. J Eur Acad Dermatol Venereol. 2000;14(5):424–425. doi:10.1046/j.1468-3083.2000.00090-3.x
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148–155. doi:10.1016/j.jaad.2017.08.037
   PubMed Web of Science ®Google Scholar
• Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182(5):1269–1276. doi:10.1111/bjd.18420
   PubMed Web of Science ®Google Scholar
• Tan J, Berg M, Gallo RL, Del Rosso JQ. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179(3):741–746. doi:10.1111/bjd.16815
   PubMed Web of Science ®Google Scholar
• Woo YR, Han YJ, Kim HS, Cho SH, Lee JD. Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the Gut–Brain–Skin Axis. Int J Mol Sci. 2020;21(22):8427. doi:10.3390/ijms21228427
   PubMed Web of Science ®Google Scholar
• Wang FY, Chi CC. Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and Gut–Skin Axis of rosacea. Adv Ther. 2021;38:1415–1424. doi:10.1007/s12325-021-01624-x
   PubMed Web of Science ®Google Scholar
• Pathan S, Gowdy RE, Cooney R, et al. Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. Tissue Antigens. 2009;74(4):322–329. doi:10.1111/j.1399-0039.2009.01314.x
   PubMedGoogle Scholar
• Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterial overgrowth in rosacea: a 3-year follow-up. J Am Acad Dermatol. 2016;75:113–115. doi:10.1016/j.jaad.2016.01.059
   PubMed Web of Science ®Google Scholar
• Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6:759–764. doi:10.1016/j.cgh.2008.02.054
   PubMed Web of Science ®Google Scholar
• Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the Gut-Skin Axis. Front Microbiol. 2018;9:1459. doi:10.3389/fmicb.2018.01459
   PubMed Web of Science ®Google Scholar
• Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol. 2013;68:875–876. doi:10.1016/j.jaad.2012.11.038
   PubMed Web of Science ®Google Scholar
• Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74(4):667–672. doi:10.1016/j.jaad.2015.11.004
   PubMed Web of Science ®Google Scholar
• Choi JE, Di Nardo A. Skin neurogenic inflammation. Semin Immunopathol. 2018;40:249–259. doi:10.1007/s00281-018-0675-z
   PubMed Web of Science ®Google Scholar
• Schwab V, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;V15(1):53–62. doi:10.1038/jidsymp.2011.6
   Google Scholar
• Jang Y, Sim J, Kang H, Kim Y, Lee E-S. Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea. J Eur Acad Dermatol Venereol. 2011;25(5):544–548. doi:10.1111/j.1468-3083.2010.03825.x
   PubMed Web of Science ®Google Scholar
• Ahn CS, Huang WW. Rosacea Pathogenesis. Dermatol Clin. 2018;36(2):81–86. doi:10.1016/j.det.2017.11.001
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH, Epstein FH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801–1811. doi:10.1056/NEJM199906103402306
   PubMed Web of Science ®Google Scholar
• Wu WH, Geng H, Cho E, et al. Reproductive and hormonal factors and risk of incident rosacea among US White women. J Am Acad Dermatol. 2022;87(1):138–140. doi:10.1016/j.jaad.2021.06.865
   PubMed Web of Science ®Google Scholar
• Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017;7(4):31–37. doi:10.5826/dpc.0704a08
   PubMedGoogle Scholar
• Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501–1510. doi:10.1016/j.jaad.2020.01.077
   PubMed Web of Science ®Google Scholar
• Wolf JE, Del Rosso JQ. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis. 2007;79(1):73–80.
   PubMed Web of Science ®Google Scholar
• Yuraitis M, Jacob CI. Botulinum toxin for the treatment of facial flushing. Dermatol Surg. 2004;30:102–104. doi:10.1111/j.1524-4725.2004.30017.x
   PubMed Web of Science ®Google Scholar
• Dahan S. Laser and intense pulsed light management of couperose and rosacea. Ann Dermatol Venereol. 2011;138(Suppl 3):219–222. doi:10.1016/S0151-9638(11)70094-1
   PubMedGoogle Scholar
• Baskan EB, Belli AA. Evaluation of long-term efficacy, safety, and effect on life quality of pulsed dye laser in rosacea patients. J Cosm Las Ther. 2019;21(4):185–189. doi:10.1080/14764172.2018.1502453
   PubMed Web of Science ®Google Scholar
• Maxwell EL, Ellis DA, Manis H. Acne rosacea: effectiveness of 532 nm laser on the cosmetic appearance of the skin. J Otolaryngol Head Neck Surg. 2010;39(3):292–296.
   PubMed Web of Science ®Google Scholar
• Alam M, Voravutinon N, Warycha M, et al. Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trial. J Am Acad Dermatol. 2013;69(3):438–443. doi:10.1016/j.jaad.2013.04.015
   PubMed Web of Science ®Google Scholar
• Goo BL, Kang JS, Cho SB. Treatment of early-stage erythematotelangiectatic rosacea with a Q-switched 595-nm Nd:YAG laser. J Cosmet Laser Ther. 2015;17(3):139–142. doi:10.3109/14764172.2014.1003239
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Lehmann P. Physical modalities for the treatment of rosacea. J Dtsch Dermatol Ges. 2016;14:38–43.
   Web of Science ®Google Scholar
• Addor FA. Skin barrier in rosacea. An Bras Dermatol. 2016;91(1):59–63. doi:10.1590/abd1806-4841.20163541
   PubMed Web of Science ®Google Scholar
• Kresken J, Kindl U, Wigger-Alberti W, Clanner-Engelshofen BM, Reinholz M. Dermocosmetics for use in rosacea: guideline of the Society for Dermopharmacy. Skin Pharmacol Physiol. 2018;31:147–154. doi:10.1159/000486688
   PubMed Web of Science ®Google Scholar
• Algiert-Zielińska B, Mucha P, Rotsztejn H. Lactic and lactobionic acids as typically moisturizing compounds. Int J Dermatol. 2019;58(3):374–379. doi:10.1111/ijd.14202
   PubMed Web of Science ®Google Scholar
• Chen W, He M, Xie L, Li L. The optimal cleansing method for the removal of sunscreen: water, cleanser or cleansing oil? J Cosmet Dermatol. 2020;19(1):180–184. doi:10.1111/jocd.12995
   PubMed Web of Science ®Google Scholar
• Li G, Wang B, Zhao Z, et al. Excessive cleansing: an underestimating risk factor of rosacea in Chinese population. Arch Dermatol Res. 2021;313(4):225–234. doi:10.1007/s00403-020-02095-w
   PubMed Web of Science ®Google Scholar
• Jensen JM, Proksch E. The skin’s barrier. G Ital Dermatol Venereol. 2009;144(6):689–700.
   PubMed Web of Science ®Google Scholar
• Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139(11):1444–1450. doi:10.1001/archderm.139.11.1444
   PubMedGoogle Scholar
• Bageorgou F, Vasalou V, Tzanetakou V, Kontochristopoulos G. The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea. J Cosmet Dermatol. 2019;18(2):563–567. doi:10.1111/jocd.12724
   PubMed Web of Science ®Google Scholar
• Domingo DS, Camouse MM, Hsia AH, et al. Anti-angiogenic effects of epigallocatechin-3-gallate in human skin. Int J Clin Exp Pathol. 2010;3(7):705–709.
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Kalogeromitros D, Gregoriou S, et al. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea. J Eur Acad Dermatol Venereol. 2005;19(5):564–568. doi:10.1111/j.1468-3083.2005.01248.x
   PubMed Web of Science ®Google Scholar
• Działo M, Mierziak J, Korzun U, Preisner M, Szopa J, Kulma A. The potential of plant phenolics in prevention and therapy of skin disorders. Int J Mol Sci. 2016;17(2):160. doi:10.3390/ijms17020160
   PubMed Web of Science ®Google Scholar
• Emer J, Waldorf H, Berson D. Botanicals and anti-inflammatories: natural ingredients for rosacea. Semin Cutan Med Surg. 2011;30(3):148–155. doi:10.1016/j.sder.2011.05.007
   PubMed Web of Science ®Google Scholar
• Gonçalves MMBM, Pina MESRT. Dermocosmetic care for rosacea. Braz J Pharm Sci. 2017;53(4):e00182. doi:10.1590/s2175-97902017000400182
   Web of Science ®Google Scholar
• Abdullah GA. The effectiveness of topical vitamin K cream 1% in the treatment of steroid-induced rosacea. Res J Pharm and Tech. 2020;13(8):3883–3886. doi:10.5958/0974-360X.2020.00687.3
   Google Scholar
• Hoffmann J, Gendrisch F, Schempp SM, Wölfle U. New herbal biomedicines for the topical treatment of dermatological disorders. Biomedicines. 2020;8(2):27. doi:10.3390/biomedicines8020027
   PubMed Web of Science ®Google Scholar
• Fisk WA, Lev-Tov HA, Clark AK, Sivamani RK. Phytochemical and botanical therapies for rosacea: a systematic review. Phytother Res. 2015;29(10):1439–1451. doi:10.1002/ptr.5432
   PubMed Web of Science ®Google Scholar
• Reinholz M, Tietze JK, Kilian K, et al. Rosacea - S1 Guideline. J Dtsch Dermatol Ges. 2013;11(8):768–780. doi:10.1111/ddg.12101
   PubMed Web of Science ®Google Scholar
• Cole C, Shyr T, Ou-Yang H. Metal oxide sunscreens protect skin by absorption, not by reflection or scattering. Photodermatol Photoimmunol Photomed. 2016;32(1):5–10. doi:10.1111/phpp.12214
   PubMed Web of Science ®Google Scholar
• Bewley A, Fowler J, Schöfer H, et al. Erythema of rosacea impairs health-related quality of life: results of a meta-analysis. Dermatol Ther. 2016;6:237–247.
   Web of Science ®Google Scholar
• Seité S, Deshayes P, Dréno B, et al. Interest of corrective makeup in the management of patients in dermatology. Clin Cosmet Investig Dermatol. 2012;5:123–128. doi:10.2147/CCID.S33172
   PubMedGoogle Scholar
• Peuvrel L, Quéreux G, Brocard A, et al. Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses. Dermatology. 2012;224:374–380. doi:10.1159/000339478
   PubMed Web of Science ®Google Scholar
• Huang YX, Li J, Zhao ZX, et al. Effects of skin care habits on the development of rosacea: a multi-center retrospective case-control survey in Chinese population. PLoS One. 2020;15(4):e0231078. doi:10.1371/journal.pone.0231078
   PubMed Web of Science ®Google Scholar
• Iredale J, Linder J. Mineral makeup and its role with acne and rosacea. Cosmet Dermatol. 2009;22(8):407–412.
   Google Scholar